Zilbrix-Hib

Zilbrix-Hib appears to be a brand or trade name for a Haemophilus influenzae type b (Hib) conjugate vaccine. Hib vaccines are used to prevent invasive diseases caused by Haemophilus influenzae type b, such as meningitis, epiglottitis, pneumonia, and septic arthritis in young children. These vaccines work by inducing the immune system to produce antibodies against the polysaccharide capsule of Hib bacteria. The polysaccharide is conjugated (chemically linked) to a carrier protein—commonly tetanus toxoid—to enhance immunogenicity in infants and young children[1][2][3]. While "Zilbrix-Hib" itself is not directly referenced in major regulatory or medical sources as of June 2025, it likely follows the same mechanism and formulation principles as other Hib conjugate vaccines.

Brand names

Zilbrix-Hib